Observatory · observe first

Follow the allocation change

Matched S&P 500 members → sector → industry → sub-industry → company. Each step uses the same percentage points.

Historical time machine
Historical observation
20182026
Universe›Health Care›Biotechnology›Biotechnology

1 · Sector

Weight and 12M allocation change

Utilities99.9%+96.11 ppMaterials0.0%-2.52 ppCommunication Services0.0%-3.57 ppReal Estate0.0%-3.65 ppEnergy0.0%-4.33 ppConsumer Discretionary0.0%-7.10 ppConsumer Staples0.0%-8.79 ppIndustrials0.0%-14.17 ppFinancials0.0%-16.46 ppInformation Technology0.0%-17.45 ppHealth Care0.0%-18.06 pp

2 · Industry

Inside Health Care

Pharmaceuticals0.00%-6.10 ppHealth Care Equipment0.00%-3.32 ppBiotechnology0.00%-2.84 ppManaged Health Care0.00%-2.16 ppLife Sciences Tools & Services0.00%-1.82 ppHealth Care Services0.00%-1.01 ppHealth Care Distributors0.00%-0.39 ppHealth Care Facilities0.00%-0.28 ppHealth Care Supplies0.00%-0.14 ppHealth Care Technology0.00%+0.00 pp

3 · Sub-industry

Inside Biotechnology

Biotechnology0.00%-2.837 pp
Broad

The loss is shared across much of the industry.

View all contributions →
Biotechnology · weight
0.00%
Industry change · 12M
-2.84 pp
Biotechnology · contribution
-2.837 pp
Company participation
0%
of industry constituents above their 6M weight average

4 · Companies driving this sub-industry

Feb 2020 · sorted by absolute contribution to 12-month change

CompanyCountryMarket capUniverse weight3M contribution12M contribution12M price returnAbove 6M weight average
Amgen →
AMGN
United States$117.8bn0.000%-0.702 pp-0.685 pp+8.2%No
AbbVie →
ABBV
United States$126.8bn0.001%-0.653 pp-0.677 pp+14.4%No
Gilead Sciences →
GILD
United States$87.6bn0.000%-0.428 pp-0.480 pp+10.8%No
Biogen →
BIIB
United States$53.7bn0.000%-0.272 pp-0.374 pp-6.0%No
Vertex Pharmaceuticals →
VRTX
United States$58.1bn0.000%-0.287 pp-0.279 pp+18.7%No
Regeneron Pharmaceuticals →
REGN
United States$41.8bn0.000%-0.174 pp-0.234 pp+3.2%No
Incyte →
INCY
United States$16.3bn0.000%-0.102 pp-0.107 pp-12.5%No

Company contributions use weights among matched S&P 500 members and add through each level without rescaling. Companies without matched shares and prices are omitted. These observations do not establish official index weights or actual fund flows.